07 Jun 2018 [2018] CAT 11; [2018] Comp AR 324, CAT
25 Jul 2018 [2018] CAT 12, CAT
10 Mar 2020 (European Commission intervening) [2020] EWCA Civ 339; [2020] Bus LR 803; [2020] 4 All ER 934; [2020] 2 All ER (Comm) 891; [2020] 4 CMLR 18; [2020] WLR (D) 164, CA (Sir Geoffrey Vos C, Green LJ, Sir Stephen Richards)
COMPETITION — Abuse of dominant position — Unfair price — Case law establishing prices abusive if excessive and unfair — Correct methodology to determining whether prices excessive — Whether competition authority required to construct hypothetical benchmark price — Whether two tests for determining unfairness mutually exclusive — Nature and extent of competition authority’s duty to evaluate evidence adduced by undertaking — Competition Act 1998 (c 41), s 18 — FEU Treaty, art 102
[2020] EWCA Civ 339; [2020] Bus LR 803; [2020] 4 All ER 934; [2020] 2 All ER (Comm) 891; [2020] 4 CMLR 18; [2020] WLR (D) 164, CA
Competition and Markets Authority v Flynn Pharma Ltd [2018] CAT 11; [2018] Comp AR 324, CAT
Decision of the Competition Appeal Tribunal affirmed
Competition and Markets Authority v Flynn Pharma Ltd [2020] EWCA Civ 339; [2020] Bus LR 803; [2020] 4 All ER 934; [2020] 2 All ER (Comm) 891; [2020] 4 CMLR 18; [2020] WLR (D) 164, CA
To cancel your subscription, please click the Cancel subscription button below and we will process your request as soon as possible.
We use cookies on this website, you can read our Privacy and Cookies Policy. To use website as intended please Accept Cookies